LONG TERM FOLLOW UP OF LOCALIZED, PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB AND CHOP

被引：0
|
作者：
Kobayashi, Y. [1 ]
Hatta, Y. [1 ]
Hojo, A. [1 ]
Kura, Y. [2 ]
Miura, K. [1 ]
Iriyama, N. [1 ]
Kobayashi, S. [1 ]
Sawada, U. [2 ]
Sugitani, M. [3 ]
Takeuchi, J. [1 ]
机构：
[1] Nihon Univ, Sch Med, Dept Hematol & Rheumatol, Tokyo, Japan
[2] Kasukabe Municipal Hosp, Dept Hematol & Oncol, Saitama, Japan
[3] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [41] Primary gastric diffuse large B-cell lymphoma presenting as dysphagia
    Syed, Umer
    Sidhu, Loveleen
    Tiba, Melik
    Alkhawam, Hassan
    Anyadike, Nnaemeka
    Aron, Joshua
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (04): : 503 - 504
  • [42] Spontaneous remission of primary diffuse large B-cell gastric lymphoma
    Jiro Watari
    Yusuke Saitoh
    Mikihiro Fujiya
    Kazumasa Nakamura
    Yuhei Inaba
    Kotaro Okamoto
    Hiroki Tanabe
    Atsumi Yasuda
    Naoyuki Miyokawa
    Yutaka Kohgo
    Journal of Gastroenterology, 2005, 40 : 414 - 420
  • [43] Results of CHOP chemotherapy for diffuse large B-cell lymphoma
    Hallack Neto, A. E.
    Pereira, J.
    Beitler, B.
    Chamone, D. A. F.
    Llacer, P. D.
    Dulley, F. L.
    Macedo, M. C. M. A.
    Chaoubah, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (10) : 1315 - 1322
  • [44] Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation
    Ganesan, P.
    Sagar, T. G.
    Kannan, K.
    Radhakrishnan, V
    Rajaraman, S.
    John, A.
    Sundersingh, S.
    Mahajan, V
    Ganesan, T. S.
    INDIAN JOURNAL OF CANCER, 2017, 54 (02) : 430 - 435
  • [45] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [46] OUTCOMES IN PATIENTS WITH PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA AFTER RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R-CHOP) CHEMOTHERAPY
    Suh, C.
    Sohn, B. S.
    Yoon, D. H.
    Kim, S.
    Lee, D. H.
    Kim, S. W.
    Huh, J. R.
    Lee, J. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 650 - 650
  • [47] Outcomes in patients with primary gastric diffuse large B-cell lymphoma after rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy
    Sohn, B.
    Yoon, D.
    Kim, S.
    Lee, D.
    Kim, S.
    Huh, J.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Combined modality for localized gastric diffuse large B-cell lymphoma: Long-term outcomes of 50 patients.
    Fregonese, Beatrice
    Imber, Brandon S.
    Dreyfuss, Alexandra
    Boe, Lillian A.
    Hajj, Carla
    Yahalom, Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP
    Yoon, Dok Hyun
    Choi, Dae Ro
    Ahn, Heui June
    Kim, Shin
    Lee, Dae Ho
    Kim, Sang-We
    Park, Bong-Hee
    Yoon, Sun Och
    Huh, Jooryung
    Lee, Sang-Wook
    Suh, Cheolwon
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (02) : 149 - 157
  • [50] KI-67 EXPRESSION IS PREDICTIVE OF PROGNOSIS IN PATIENTS OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP
    Suh, C.
    Yoon, D. H.
    Sohn, B. S.
    Kim, J. E.
    Yoo, C. H.
    Kim, S.
    Lee, D. H.
    Huh, J. R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 402 - 403
12345